Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
D000818:Animals; D001379:Azathioprine / Q000627:therapeutic use; D001806:Blood Urea Nitrogen; D003601:Cytotoxicity Tests, Immunologic; D004285:Dogs; D004359:Drug Therapy, Combination; D000939:Epitopes; D006084:Graft Rejection / Q000187:drug effects*; D007112:Immunity, Maternally-Acquired; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage / Q000627:therapeutic use*; D007074:Immunoglobulin G / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007275:Injections, Intravenous; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use; D010477:Perfusion; D014181:Transplantation Immunology / Q000187:drug effects*; D014184:Transplantation, Homologous
D000939:Epitopes; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D001379:Azathioprine; D008775:Methylprednisolone